Clinical trials, pathologies and developments in personalized medicine
Francesco d'Amore et al.
Novel targets for AML
Ponatinib and its role in treating ALL
What is the future of treating ALL?
CAR T-cells for CLL: ibrutinib pre-treatment, T-cell quality and future predictions